Transthyretin Amyloid Cardiomyopathy in Aortic Stenosis Patients Scheduled for Transcatheter Aortic Valve Implantation
ESC Heart Failure · 01.08.2025 · 12 (4) · 2467-2476
DOI: 10.1002/ehf2.15258 ↗Kurz gefasst
Fachartikel in der Zeitschrift ESC Heart Failure, online erschienen am 11.03.2025. Verfasst von Margrethe Flesvig Holt und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Oslo University Hospital, Rikshospitalet, Oslo, Norway. Hauptthemen laut MEDLINE: Aortic Valve Stenosis, Transcatheter Aortic Valve Replacement, Cardiomyopathies, Amyloid Neuropathies, Familial. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Bergesen Foundation, Pfizer.
Abstract (Originalsprache)
Aims
The prevalences of aortic stenosis (AS) and transthyretin amyloid cardiomyopathy (ATTR-CM) increase with age. Identification of occult ATTR-CM in patients with AS can help explain out-of-proportion myocardial dysfunction, aid in prognostication and prompt initiation of disease-modifying treatment. Studies have suggested that many patients referred for transcatheter aortic valve implantation (TAVI) have concomitant ATTR-CM, but some have included unverified ATTR-CM in patients with ambiguous scintigrams. We aimed to assess the co-occurrence of ATTR-CM in patients scheduled for TAVI.
Methods
In patients accepted for TAVI for severe AS, we used bone scintigraphy to screen for ATTR-CM. We defined ATTR-CM as a cardiac tracer uptake ≥ Perugini Grade 2 in the absence of abnormal monoclonal protein or abnormal free light chain ratio. We offered bioptic verification to patients with Grade 1 or ambiguous DPD uptake.
Results
We included 171 consecutive patients aged 79 ± 7 years, 57% were male. Six patients (3.5%) had cardiac bone tracer uptake ≥ Perugini Grade 2 and no abnormal monoclonal protein/free light chains. Endomyocardial biopsies confirmed the diagnosis in two additional patients (1.2%), whereas five patients with low-grade uptake did not have ATTR-CM. In total, 8/171 patients (4.7%) were diagnosed with concomitant AS and ATTR-CM. Most of the patients with concomitant ATTR-CM had low-flow low-gradient (LFLG) AS, and 25% had a history of carpal tunnel syndrome.
Conclusions
We found concomitant AS and ATTR-CM in 5% of our TAVI patients. Carpal tunnel syndrome and LFLG AS suggest concomitant ATTR.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiology, Oslo University Hospital, Rikshospitalet, Oslo, Norway.
- Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.
- KG Jebsen Center for Cardiac Research, University of Oslo, Oslo, Norway.
- Department of Nuclear Medicine, Oslo University Hospital, Oslo, Norway.
- ProCardio Center for Innovation, Department of Cardiology, Rikshospitalet, Oslo University Hospital, Oslo, Norway.
- Department of Pathology, Oslo University Hospital, Rikshospitalet, Oslo, Norway.
Förderung
- Bergesen Foundation
- Pfizer
Zitieren
APA
Holt, M. F., Flø, A., Kaya, E., Kløve, S. F., Martinsen, H., Amlie, K., Storsten, P., Mathiisen, T. M., Russell, K., Eek, C. H., Skulstad, H., Raki, M., Gullestad, L., Hodt, A., Gude, E., & Broch, K. (2025). Transthyretin Amyloid Cardiomyopathy in Aortic Stenosis Patients Scheduled for Transcatheter Aortic Valve Implantation. ESC Heart Failure, 12(4), 2467-2476. https://doi.org/10.1002/ehf2.15258
Vancouver
Holt MF, Flø A, Kaya E, Kløve SF, Martinsen H, Amlie K, et al. Transthyretin Amyloid Cardiomyopathy in Aortic Stenosis Patients Scheduled for Transcatheter Aortic Valve Implantation. ESC Heart Failure. 2025;12(4):2467-2476. doi:10.1002/ehf2.15258
BibTeX
@article{Holt2025,
author = {Holt, Margrethe Flesvig and Flø, August and Kaya, Esra and Kløve, Sophie Foss and Martinsen, Hege and Amlie, Kristine and Storsten, Petter and Mathiisen, Thomas Misje and Russell, Kristoffer and Eek, Christian Hesbø and Skulstad, Helge and Raki, Melinda and Gullestad, Lars and Hodt, Anders and Gude, Einar and Broch, Kaspar},
title = {Transthyretin Amyloid Cardiomyopathy in Aortic Stenosis Patients Scheduled for Transcatheter Aortic Valve Implantation},
journal = {ESC Heart Failure},
year = {2025},
volume = {12},
number = {4},
pages = {2467--2476},
doi = {10.1002/ehf2.15258}
}
EUVIMED